Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
about
Hydrogen bonding and anticancer properties of water-soluble chiral p-cymene Ru(II) compounds with amino-oxime ligandsGemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed.Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator.The evolving biology and treatment of prostate cancer.Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancerAn open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors.Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cellsEmerging drugs for prostate cancer.Satraplatin for the therapy of castration-resistant prostate cancer.Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.Second-line therapy for castrate-resistant prostate cancer: a literature review.Clinical and pharmacokinetic evaluation of satraplatin.Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity.Natural compounds to overcome cancer chemoresistance: toxicological and clinical issues.Prognostic significance of focal neuroendocrine differentiation in prostate cancer: cases with autopsy-verified cause of death.Cabazitaxel for the treatment of castration-resistant prostate cancer.Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.Induction of multinucleated cells and apoptosis in the PC-3 prostate cancer cell line by low concentrations of polyethylene glycol 1000.ECF chemotherapy for liver metastases due to castration-resistant prostate cancer.Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study.
P2860
Q28834484-EDBC9938-41DE-450A-86FC-FDE626CE39C6Q33414629-B0BE14DF-FAE7-41B3-8817-5927ABD9518CQ33986172-29E96A4B-0225-41F6-817C-77BC250F52BEQ35951473-D4F051FE-9DCD-484D-8EC7-42CB12CBCC8CQ36241242-4F1E7391-91DB-43D2-8822-5DDAAD1201DCQ36417757-8771AC59-C876-4C29-B524-A1E1C9588B0EQ36826103-EEFCFB22-95FA-4E6D-92CC-A79745C72FDEQ37038041-3F2BFF48-8C1A-4EAE-8A6B-97C3260521D0Q37123431-31E01618-F4EB-4162-887A-A388002262AAQ37570555-2A61E326-9A8E-4468-99B1-D2AC5ACD5B5BQ37605845-2EECC4C2-2854-4EF2-A2B3-11CC00D48AB8Q37677557-EAF8591C-C35A-4F58-BD4A-31C9F03A5652Q37925129-C3B323E4-7A3F-4087-95B5-4D0061A4DCEBQ37958009-4D3DAAFF-432A-47AD-92FF-458EB60E793BQ38123245-78ABF64E-5F78-4A96-B4AC-C892ADD72FA9Q38262078-DFAFC2C2-A5E0-405A-A00B-5D621C3032C2Q38416151-EA71CC27-42E1-43EB-9644-EBABD06C0455Q38861952-FD9F2CB0-39EA-4C27-9B74-299BA114B0AAQ39982891-B5CB8C18-B32A-4F61-A2BB-BF82183D6E1FQ39996400-3BD37B67-3CCE-42D4-B759-BC246F7C4F25Q42970939-8B26BE14-FA7D-407E-9626-E4FE906A7635Q54631608-8C1BB214-F0D1-44E7-AD9E-2746F2BD34E1
P2860
Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Is there a role for platinum c ...... ne-refractory prostate cancer?
@ast
Is there a role for platinum c ...... ne-refractory prostate cancer?
@en
type
label
Is there a role for platinum c ...... ne-refractory prostate cancer?
@ast
Is there a role for platinum c ...... ne-refractory prostate cancer?
@en
prefLabel
Is there a role for platinum c ...... ne-refractory prostate cancer?
@ast
Is there a role for platinum c ...... ne-refractory prostate cancer?
@en
P2860
P356
P1433
P1476
Is there a role for platinum c ...... ne-refractory prostate cancer?
@en
P2093
Jiaoti Huang
Miah-Hiang Tay
P2860
P304
P356
10.1002/CNCR.22439
P407
P577
2007-02-01T00:00:00Z